Bloomberg Law
April 11, 2023, 10:00 AM

Conflicting Rulings Over Abortion Pill Add to Chaos Over Access

Madlin Mekelburg
Madlin Mekelburg
Bloomberg News

Dueling Friday night rulings over the legality and availability of mifepristone, also known as the abortion pill, are the most significant turn yet in what’s shaping up to be the biggest fight over reproductive rights in the US since the overturning of Roe v. Wade in June.

US District Judge Matthew Kacsmaryk of the Northern District of Texas temporarily suspended the Food and Drug Administration’s decades-old approval of mifepristone, the only pill specifically approved for abortion in the country. His directive is set to take effect on April 14, but it was followed moments later by a contradictory ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.